SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-301149
Filing Date
2022-12-09
Accepted
2022-12-08 17:47:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d421217d424b5.htm 424B5 565958
2 GRAPHIC g421217g01y00.jpg GRAPHIC 31144
3 GRAPHIC g421217g02y00.jpg GRAPHIC 41745
  Complete submission text file 0001193125-22-301149.txt   659955
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249544 | Film No.: 221453320
SIC: 2836 Biological Products, (No Diagnostic Substances)